Research Support & Innovation Grant Results
(Funding rate = 50%)
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Shokrollah Elahi | $40,000 | Elevated levels of succinate in breastmilk of mothers with IBD may predispose infants to immunological disorders |
| Hanne Ostergaard | $40,000 | The role of leupaxin in regulating the immune response to influenza infection |
| TOTAL | $80,000 |
Research Support & Innovation Grants 2022 – Summer Competition
(Funding rate = 83.3%)
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Troy Baldwin | $40,000 | The role of Nur77 in regulating T cell responses |
| Michael Houghton | $40,000 | Development of highly accurate low-cost electronic medical diagnostic devices using graphene field effect transistor (GFET) technology |
| David Marchant | $40,000 | TLR7 is a therapeutic target for Respiratory Syncytial Virus infection |
| Lisa Willis | $40,000 | Regulation of T cell activation by the immunomodulatory glycan polysialic acid |
| Stephanie Yanow | $40,000 | Unravelling the role of extracellular vesicles in the pathogenesis of placental malaria |
| TOTAL | $200,000 |
Research Support & Innovation Grants 2021 – Winter Competition
(Funding rate = 85.7%)
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Xavier Clemente-Casares | $40,000 | The role of tumor-derived granulocytic growth factors in cancer cachexia |
| Shokrollah Elahi | $40,000 | Understanding the biology associated with COVID-19 long-haulers for clinical interventions |
| Wael Elhenawy | $40,000 | Delineating the molecular mechanisms of bacterial virulence during Crohn’s disease |
| Edan Foley | $40,000 | Identification of biomarkers of mucosal immune responses to a Vibrio cholerae infection |
| Vanessa Meier-Stephenson | $40,000 | Proving a G-quadruplex target in HBV's chronic form can be targeted selectively |
| Michael Woodside | $40,000 | Developing candidates for broad-spectrum anti-coronaviral drugs that target programmed ribosomal frameshifting |
| TOTAL | $240,000 |
Research Support & Innovation Grants 2021 – Summer Competition
(Funding rate = 50%)
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Sue Tsai | $40,000 | Modulation of Type 1 diabetes development by IgA-mediated mucosal immunity |
| TOTAL | $40,000 |
Research Support & Innovation Grants 2020 – Winter Competition
(Funding rate = 80%)
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Khaled Barakat | $40,000 | Rational design & development of pan-serotype small molecule antivirals against dengue & zika viral infections |
| Amit Bhavsar | $40,000 | Examining selective inhibition and preclinical utility of protective agents against cisplatin-induced hearing loss |
| Denise Hemmings | $40,000 | Latent cytomegalovirus infections increase lung metastasis: Impact on "seed" and "soil" |
| Robert Ingham | $40,000 | Characterizing poxvirus interactions with the host ubiquitin system in order to treat disease |
| TOTAL | $160,000 |
Research Support & Innovation Grants 2020 – Summer Competition
(Funding rate = 66.7%)
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Carlos Cervera | $40,000 | The urine microbiome and virome in kidney transplant patients with recurrent urinary tract infections. A new approach for future therapeutic changes |
| Sue Tsai | $40,000 | Yap and Taz-mediated mechanosensing in dendritic cells |
| TOTAL | $80,000 |
Research Support & Innovation Grants 2019 – Winter Competition
(Funding rate = 36.4%)
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Amit Bhavsar | $40,000 | Development of otoprotective immune inhibitors to mitigate drug-induced hearing loss |
| Edan Foley | $40,000 | Identification of druggable targets for the modification of Vibrio cholerae pathogenesis |
| Mary Hitt | $40,000 | Advancing neurooncology treatment options by combining oncolytic viral therapy with image-guided radiation therapy |
| Maya Shmulevitz | $40,000 | Reovirus-based wild-life vaccine for zoonotic pathogens |
| TOTAL | $160,000 |
Research Support & Innovation Grants 2019 – Summer Competition
(Funding rate = 66.7%)
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Xavier Clemente-Casares | $40,000 | The Role of Cardiac Immune Immaturity in Pediatric Viral Myocarditis Outcomes |
| David Evans | $40,000 | MHC-I Complexed Peptide Antigens |
| Michael Hawkes | $40,000 | Biomarkers of Childhood Pneumonia |
| Jack Tuszynski | $40,000 | Testing Ribosomal Frameshift Inhibitors as Potential Anti-Viral Therapeutics for West-Nile Virus |
| TOTAL | $160,000 |
Research Support & Innovation Grants 2018
(Funding rate = 42.8%)
| INVESTIGATOR(S) | AMOUNT | PROJECT TITLE |
|---|---|---|
| Shokrollah Elahi | $40,000 | Development of a Novel Live Microbicide to Prevent sand Eliminate HIV Infection |
| Xiao-Li Lilly Pang | $39,300 | Optimization of a New Model for Replicating Human Norovirus in Human Intestinal Enteroids |
| Stephanie Yanow | $40,000 | Advanced Epitope Mining for a Vaccine to Prevent Placental Malaria Infections |
| TOTAL | $119,300 |